T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies

Patients affected by lymphoid malignancies (LM) are frequently immune‐compromised, suffering increased mortality from COVID‐19. This prospective study evaluated serological and T‐cell responses after complete mRNA vaccination in 263 patients affected by chronic lymphocytic leukaemia, B‐ and T‐cell l...

Descripción completa

Detalles Bibliográficos
Autores principales: Marasco, Vincenzo, Carniti, Cristiana, Guidetti, Anna, Farina, Lucia, Magni, Martina, Miceli, Rosalba, Calabretta, Ludovica, Verderio, Paolo, Ljevar, Silva, Serpenti, Fabio, Morelli, Daniele, Apolone, Giovanni, Ippolito, Giuseppe, Agrati, Chiara, Corradini, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid‐19
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653177/
https://www.ncbi.nlm.nih.gov/pubmed/34649298
http://dx.doi.org/10.1111/bjh.17877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8653177/
https://www.ncbi.nlm.nih.gov/pubmed/34649298
http://dx.doi.org/10.1111/bjh.17877

Ejemplares similares